Intellectual Property

Intellectual Property

Our HEALER technology provides the foundation for strong IP protection based on composition of matter, methods of treatment, process, formulation and physical combination claims. We have issued patents providing long-term market exclusivity in the United States and Europe through 2034-37. In addition, Thetis' drug candidates are eligible for patent term extension and 5-year new chemical entity status. Patents are pending in Asia and other major markets.